Most clinical studies involving rheumatoid factors are made on sera; relatively few investigations are reported on rheumatoid factors in joint fluid, connective tissue extracts, interstitial fluid and cells. Joint fluid of patients with rheumatoid arthritis often contains rheumatoid factor, measured by the latex fixation and sheep cell agglutination tests.,"'8 Mellors, et al.' established evidence that in patients with rheumatoid arthritis, rheumatoid factor is synthesized by plasma cells in at least three tissues, lymph nodes, rheumatoid nodules and synovialis. Since plasma cells do not circulate, the rheumatoid factor molecule probably appears first in connective tissues and moves to serum, presumably via the lymphatic system. Krehl, et al. ' reported results of sheep cell agglutination tests on simultaneously collected sera and joint fluids from patients with rheumatoid arthritis and certain other diseases. Joint fluid tests were less often positive than serum tests, but when joint fluid was positive, it was so in higher titer than serum. Joint fluids were examined before and after incubation with hyaluronidase. Fluids showing positive tests before hyaluronidase treatment did not change after incubation. However, significant numbers of tests previously negative became positive after hyaluronidase treatment.
Except for its hyaluronic acid content joint fluid is regarded as having the chemical composition of an ultrafiltrate of plasma; since hyaluronidase specifically hydrolyzes hyaluronic acid, and the sheep cell agglutination tests in joint fluid, previously negative, disclosed positive tests after hyaluronidase treatment, Krehl, et al.' interpreted the change to positivity as being due to some change in hyaluronic acid or a consequence of such change. One possibility is that a protein in complex with hyaluronic acid in joint fluid is released to react with sensitized sheep cells, being incapable of reaction when bound to polysaccharide.
To further test the hypothesis that treatment of sera and joint fluids with hyaluronidase changes the result of sheep cell agglutination and latex fixation tests, contemporary sera and joint fluids were collected from three groups of patients and tested as outlined below.* with blood. Knee joints were surgically opened in post mortem subjects of Group B. The fluids were centrifuged to remove any fibrin clot, cells, or debris and stored at 40 C. The tests were done on paired sera and joint fluids several days later. For Groups A and B Sigma Hyalase (British) was used. It was dissolved in 0.1 molar glycerine buffer to a final concentration of 1 mg. per ml. at pH 6.0 containing 1% NaCl; 0.5 ml. hyaluronidase solution was added to 0.1 ml. serum and joint fluid respectively and incubated for twelve hours @ 370 C. At the same time 0.5 ml. of buffer was added to the control 0.5 ml. aliquots of sera and joint fluids. The change in viscosity was measured in each joint fluid. In each instance the value began to plateau five to ten minutes after addition of hyaluronidase. After incubation the sera and joint fluids were placed in the refrigerator and the sheep cell agglutination test was done the next day (Ball modification of the Rose test).' Group C was examined in the same way except that the latex fixation test, according to the method of Singer and Plotz7 was used; the incubation period with hyaluronidase was five to six hours at 370 C.; pH 6.0 was used; a pH of 8.2 was tried at varying lengths of time from one hour to 18 hours incubation at 37°; these changes in method produced no change in results. After incubation the sera and fluids were stored in the refrigerator and the latex test done the next day. Hyaluronidase (testicular) was obtained from Worthington Biochemical Company. All control tests were incubated in buffer without hyaluronidase to detect any changes occurring in storage or incubation, and to be certain that any change observed was caused by hyaluronidase.
RESULTS AND DISCUSSION
Group A. Twenty simultaneously collected samples of sera and joint fluids were examined by the sheep cell agglutination test.' A titer of 1-32 is considered positive. Table 1 lists the results. Table 2 depicts the changes after hyaluronidase treatment.
Serum changes: One patient with rheumatoid arthritis had a serum titer of 1-64 prior to and less than 1-4 after incubation; a third dropped by the same amount; two positive sera were unchanged after incubation. No negative tests became positive. Joint fluid changes: One positive fluid dropped in titer from 1-256 to less than 1-8. Two positive fluids were unchanged and one dropped in titer from 1-32 to less than 1-8.
Group B: Table 3 lists results of examples of ten knee joint fluids obtained post-mortem from patients having no known rheumatic disease. No positive tests occurred. Group C: Using the latex fixation test the 43 pairs were examined pre-and post-hyaluronidase treatment as outlined above. Table 4 lists the diagnostic categories of the patients and Table 5 shows results of latex fixation tests. Sixteen patients with definite or classic rheumatoid arthritis had strongly positive latex tests before hyaluronidase treatment in both sera and joint fluids. Nineteen tests were negative; eight were low titer positive in serum or synovial fluid or both. After incubation with hyaluronidase no changes occurred. Six of the pairs were re-examined preand post-hyaluronidase incubation two to four times with no change in the results.
Enzymatic treatment of sera and synovial fluid with hyaluronidase did not alter the latex fixation test. If rheumatoid factor or some fraction of it were combined with hyaluronic acid in joint fluid, this manipulation would, in all probability, denature the molecule sufficiently to change its reactivity. It is improbable that the reacting factor is chemically combined to hyaluronic acid. Rheumatoid factor is probably free in synovial fluid the negative tests of sera are unaltered by hyaluronidase digestion and the hyaluronic acid-protein complex of joint fluid is digested, freeing normal globulins with no effect on the titer of the test. SUMMARY 1. To determine if there is a relationship between rheumatoid factor and protein-hyaluronic acid complex of joint fluid, three groups of sera and joint fluids were collected simultaneously from a variety of patients and examined by sheep cell agglutination or latex fixation tests, pre-and post-hyaluronidase treatment.
Group A: Twenty pairs from patients with rheumatic disease (sheep cell agglutination test*-Ball.'
Group B: Ten joint fluids obtained post mortem from patients with no known rheumatic disease (sheep cell agglutination test*- Ball.6 Group C: Forty-three pairs obtained from patients with a variety of rheumatic diseases (latex fixation test).'
2. No significant changes in titer occurred in Group A tests following hyaluronidase digestion; no changes at all occurred in Groups B and C. The evidence is that rheumatoid factor, though present in joint fluid of patients with rheumatoid arthritis, is not chemically combined with hyaluronic acid. Incubation of sera and joint fluids with hyaluronidase does not significantly alter the results of the sheep cell agglutination or latex fixation tests.
